Align Technology (ALGN) Stock Price, News & Analysis

Company Overview

Align Technology, Inc. is a global medical device company specializing in orthodontic and restorative dentistry solutions. The company’s core business centers on the design, manufacture and marketing of Invisalign clear aligners, a popular alternative to traditional braces that uses advanced 3D computer imaging technology to create custom treatment plans. In addition to aligner therapy, Align offers digital scanning systems and software solutions that support dental professionals in delivering precise, efficient treatments.

In conjunction with its Invisalign product line, Align Technology develops and sells the iTero Intraoral Scanner, a digital impression system that captures detailed 3D images of patients’ teeth and gums. These scanners feed into Align’s proprietary treatment-planning software, enabling dentists and orthodontists to visualize tooth movement, simulate outcomes and fabricate restorative devices. The integration of hardware, software and manufacturing services creates a seamless digital workflow that has been widely adopted by practitioners worldwide.

Founded in 1997 by Zia Chishti and Kelsey Wirth, Align Technology has grown from a Silicon Valley start-up into a publicly traded company headquartered in Tempe, Arizona. Over the years, the company has invested heavily in research and development, securing numerous patents related to clear aligner design and digital imaging. Today, Align’s products and services are available in more than 100 countries, with regional offices and manufacturing facilities across North America, Europe, Asia Pacific and Latin America.

Align Technology is led by a seasoned management team and board of directors with deep expertise in medical devices, digital health and global operations. The company places a strong emphasis on innovation, collaboration with dental professionals and ongoing education, hosting clinical forums and training programs to advance the adoption of digital orthodontics. With a strategic focus on expanding its product portfolio and geographic reach, Align continues to shape the future of orthodontic treatment through technology-driven solutions.

Key Stats

• Today's Range: $188.50 to $193.54
• 50-Day Range: $170.80 to $204.48
• 52-Week Range: $141.74 to $262.87
• Volume: 474,609 shs
• Average Volume: 921,359 shs
• Market Capitalization: $13.83 billion
• P/E Ratio: 34.75
• Dividend Yield: N/A
• Price Target: $242.92
• Consensus Rating: Moderate Buy

Align Technology Stock Analysis - MarketRank™

Align Technology scored higher than 96% of companies evaluated by MarketBeat, and ranked 51st out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Align Technology has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 9 buy ratings, 4 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Align Technology has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 12.16%

Earnings Growth

Earnings for Align Technology are expected to grow by 12.16% in the coming year, from $7.98 to $8.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Align Technology is 34.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.51.

Price to Earnings Ratio vs. Sector

The P/E ratio of Align Technology is 34.75, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.04.

Price to Earnings Growth Ratio

Align Technology has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Align Technology has a P/B Ratio of 3.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.14% of the float of Align Technology has been sold short.

Short Interest Ratio / Days to Cover

Align Technology has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Align Technology has recently decreased by 6.95%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Align Technology does not currently pay a dividend.

Dividend Growth

Align Technology does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -1.34

Percentage of Shares Shorted

4.14% of the float of Align Technology has been sold short.

Short Interest Ratio / Days to Cover

Align Technology has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Align Technology has recently decreased by 6.95%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.75

News Sentiment

Align Technology has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 17 news articles for Align Technology this week, compared to 14 articles on an average week.

Search Interest

Only 4 people have searched for ALGN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Align Technology to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Align Technology insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.66% of the stock of Align Technology is held by insiders.

Percentage Held by Institutions

88.43% of the stock of Align Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ALGN Stock Analysis - Frequently Asked Questions

How have ALGN shares performed this year?

Align Technology's stock was trading at $208.51 on January 1st, 2025. Since then, ALGN shares have decreased by 8.5% and is now trading at $190.77.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) posted its earnings results on Wednesday, April, 30th. The medical equipment provider reported $2.13 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.13. Align Technology's quarterly revenue was down 1.8% on a year-over-year basis.
Read the conference call transcript.

Is Align Technology doing a stock buyback?

Align Technology's Board of Directors approved a share buyback plan on Tuesday, May 6th 2025, which allows the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 7.9% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's board believes its stock is undervalued.

Does Align Technology have any subsidiaries?

Align Technology subsidiaries include exocad Global Holdings GmbH (“exocad”), G.L. Dental Couture, Cadent, and Align Technology Switzerland GmbH.

Who are Align Technology's major shareholders?

Top institutional investors of Align Technology include Ninety One UK Ltd (2.64%), Swedbank AB (0.58%), Riverbridge Partners LLC (0.29%) and Robeco Institutional Asset Management B.V. (0.20%). Insiders that own company stock include Joseph M Hogan, Joseph Lacob, Warren S Thaler, C Raymond Larkin Jr, Kevin J Dallas, John Morici and Emory Wright.
View institutional ownership trends.

How do I buy shares of Align Technology?

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Align Technology investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Visa (V) and PayPal (PYPL).

Company Calendar

• Last Earnings: 4/30/2025
• Today: 7/18/2025
• Next Earnings (Confirmed): 7/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:ALGN
• CIK: 1097149
• Web: www.aligntech.com
• Phone: (602) 742-2000
• Fax: 408-470-1010
• Employees: 20,945
• Year Founded: 1997

Price Target and Rating

• Average Price Target for Align Technology: $242.92
• High Price Target: $280.00
• Low Price Target: $170.00
• Potential Upside/Downside: +27.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): $5.49
• Trailing P/E Ratio: 34.75
• Forward P/E Ratio: 23.91
• P/E Growth: 2.01
• Net Income: $421.36 million
• Net Margins: 10.29%
• Pretax Margin: 14.85%
• Return on Equity: 13.52%
• Return on Assets: 8.36%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.21
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: $4.00 billion
• Price / Sales: 3.46
• Cash Flow: $9.01 per share
• Price / Cash Flow: 21.17
• Book Value: $51.60 per share
• Price / Book: 3.70

Miscellaneous

• Outstanding Shares: 72,490,000
• Free Float: 72,007,000
• Market Cap: $13.83 billion
• Optionable: Optionable
• Beta: 1.63